A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
Enthuse M1 is a large phase III clinical trial studying the safety and efficacy of ZD4054 (Zibotentan) in patients with hormone resistant prostate cancer and bone metastases.
Inclusion Criteria:
Patients who answer TRUE to the following criteria may be eligible to participate in this trial.
Exclusion Criteria:
Patients who answer TRUE to the following may NOT eligible to participate in this trial.
Gainsville, Florida, United States
Port St.Lucie, Florida, United States
Buenos Aires, Buenos Aires, Argentina
North York, Ontario, Canada
Point-Claire, Quebec, Canada
Haidian District, Beijing Municipality, China
XI Cheng District, Beijing Municipality, China
Xicheng District, Beijing Municipality, China
Pudong New Area, Shanghai Municipality, China
Xuhui District, Shanghai Municipality, China
Kajaanintie, Kajaanintie, Finland
Bad Gegeberg, Bad Gegeberg, Germany
Gujarat, Gujarat, India
Chandigarh, Punjab, India
Kolkota, West Bengal, India
Kita-gun, Kagawa-ken, Japan
Sunto-gun, Shizuoka, Japan
Bunkyo-ku, Tokyo, Japan
Fuchu_city, Tokyo, Japan
Itabashi-Ku, Tokyo, Japan
Meguro-ku, Tokyo, Japan
Shinjuku-ku, Tokyo, Japan
Distrito Federal Ciudad, Mexico, Mexico
Saint Petersgurg, Saint Petersgurg, Russia
Tygerberg, Cape Town, South Africa
Seo-gu, Busan, South Korea
Heungduk-gu Cheongju, North Chungcheong, South Korea
Gangnam-gu, Seoul, South Korea
Songpa-gu, Seoul, South Korea
Taipei, Taipei, Taiwan